ARCHIVES

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship

October 2, 1992

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994